EHA 2023 | Challenges with immunotherapy in AML: target antigen selection, T-cell exhaustion and more
Sylvain Garciaz
• 10 Jun 2023
Sylvain Garciaz, MD, Paoli-Calmettes Institute, Marseille, France, shares some insights into a session which focused on challenges with immunotherapy in acute myeloid leukemia (AML). Dr Garciaz summarizes various issues with implementing immunotherapeutic agents in this disease, including target antigen selection, T-cell exhaustion, and the antigen sink effect. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
